基于HLA的1型糖尿病遗传风险预测在不同祖先人群中的研究
本研究利用四个祖先人群(非洲混合、美洲混合、欧洲、芬兰)的HLA区域SNP或HLA等位基因,构建了针对1型糖尿病的HLA聚焦遗传风险评分(T1D GRSHLA),并在各人群中评估其性能。结果显示,基于SNP与基于HLA等位基因的评分性能相似,ROC AUC范围0.73至0.88;跨祖先联合评分(ALL)在所有人群中表现一致良好,SNP版本AUC为0.82至0.88,HLA等位基因版本为0.80至0.87。结论认为SNP衍生模型与HLA等位基因模型等效,跨祖先联合模型具有稳定高区分度,但需更大规模多样人群研究验证可迁移性。
要点
- 基于SNP和HLA等位基因的T1D GRSHLA在不同祖先人群中性能相似。
- 跨祖先联合评分(ALL)在四个祖先人群中AUC均较高(SNP 0.82-0.88,HLA等位基因0.80-0.87)。
- 需更大规模多样人群研究进一步评估评分的跨祖先可迁移性。
核心结论
- 基于SNP的T1D GRSHLA模型与基于HLA等位基因的模型在不同祖先人群中性能等效。
- 跨祖先联合模型T1D GRSHLA-SNP-ALL和T1D GRSHLA-allele-ALL在所有祖先人群中均表现出持续较高的ROC AUC值。
研究设计与样本
- 研究对41,689个样本和HLA区域13,695个SNP进行了基因分型,并使用HLA-TAPAS多民族参考面板推断HLA等位基因。
- 在四个祖先群体(非洲混合、美洲混合、欧洲、芬兰)中识别条件独立且与1型糖尿病相关的SNP和HLA等位基因,构建T1D GRSHLA模型,并使用ROC AUC评估和比较各模型性能。
主要发现
- 各T1D GRSHLA模型包含不同数量的条件独立HLA区域SNP(AFR n=5; AMR n=3; EUR n=38; FIN n=6; ALL n=36)和HLA等位基因(AFR n=6; AMR n=5; EUR n=40; FIN n=8; ALL n=41)。
- 基于SNP或HLA等位基因的T1D GRSHLA的ROC AUC值相似,范围从0.73(T1D GRSHLA-allele-AMR应用于FIN)到0.88(T1D GRSHLA-allele-EUR应用于EUR)。
- 使用条件独立SNP联合集(T1D GRSHLA-SNP-ALL)或HLA等位基因联合集(T1D GRSHLA-allele-ALL)的ROC AUC在所有祖先群体中表现一致良好,SNP版本范围为0.82至0.88,HLA等位基因版本范围为0.80至0.87。
临床怎么用
- 基于SNP的T1D GRSHLA模型可替代基于HLA等位基因的模型用于1型糖尿病遗传风险评估,且跨祖先联合模型在不同祖先人群中具有稳定区分度。
局限性
- 需要在更多样化的人群中进行更大规模的研究,以更好地评估T1D GRSHLA跨祖先的可迁移性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Type 1 diabetes is characterised by the destruction of pancreatic beta cells. Genetic factors account for approximately 50% of the total risk, with variants in the HLA region contributing to half of this genetic risk. Research has historically focused on populations of European ancestry. We developed HLA-focused type 1 diabetes genetic risk scores (T1D GRSHLA) using SNPs or HLA alleles from four ancestry groups (admixed African [AFR; T1D GRSHLA-AFR], admixed American [AMR; T1D GRSHLA-AMR], European [EUR; T1D GRSHLA-EUR] and Finnish [FIN; T1D GRSHLA-FIN]). We also developed an across-ancestry GRS (ALL; T1D GRSHLA-ALL). We assessed the performance of the GRS in each population to determine the transferability of constructed scores. METHODS: A total of 41,689 samples and 13,695 SNPs in the HLA region were genotyped, with HLA alleles imputed using the HLA-TAPAS multi-ethnic reference panel. Conditionally independent SNPs and HLA alleles associated with type 1 diabetes were identified in each population group to construct T1D GRSHLA models. Generated T1D GRSHLA models were used to predict HLA-focused type 1 diabetes genetic risk across four ancestry groups. The performance of each T1D GRSHLA model was assessed using receiver operating characteristic (ROC) AUCs, and compared statistically. RESULTS: Each T1D GRSHLA model included a different number of conditionally independent HLA-region SNPs (AFR, n=5; AMR, n=3; EUR, n=38; FIN, n=6; ALL, n=36) and HLA alleles (AFR, n=6; AMR, n=5; EUR, n=40; FIN, n=8; ALL, n=41). The ROC AUC values for the T1D GRSHLA from SNPs or HLA alleles were similar, and ranged from 0.73 (T1D GRSHLA-allele-AMR applied to FIN) to 0.88 (T1D GRSHLA-allele-EUR applied to EUR). The ROC AUC using the combined set of conditionally independent SNPs (T1D GRSHLA-SNP-ALL) or HLA alleles (T1D GRSHLA-allele-ALL) performed uniformly well across all ancestry groups, with values ranging from 0.82 to 0.88 for SNPs and 0.80 to 0.87 for HLA alleles. CONCLUSIONS/INTERPRETATION: T1D GRSHLA models derived from SNPs performed equivalently to those derived from HLA alleles across ancestries. In addition, T1D GRSHLA-SNP-ALL and GRSHLA-allele-ALL models had consistently high ROC AUC values when applied across ancestry groups. Larger studies in more diverse populations are needed to better assess the transferability of T1D GRSHLA across ancestries.
引用
- Michalek DA, Tern C, Robertson CC, et al. HLA-focused type 1 diabetes genetic risk prediction in populations of diverse ancestry. Diabetologia. 2025. PMID: 41037100. doi:10.1007/s00125-025-06563-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。